{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:42:12Z","timestamp":1777603332425,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000382","name":"Society for Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009660","name":"London School of Hygiene and Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.wneu.2017.07.111","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T22:17:09Z","timestamp":1501021029000},"page":"1044.e5-1044.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Bevacizumab for Radiation Induced Optic Neuritis Among Aggressive Residual\/Recurrent Suprasellar Tumors: More Than a Mere Antineoplastic Effect"],"prefix":"10.1016","volume":"107","author":[{"given":"Pinaki","family":"Dutta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivashanmugam","family":"Dhandapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakamya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchan Kumar","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.07.111_bib1","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2017.07.111_bib2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2017.07.111_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in\u00a0vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"issue":"2 Suppl 1","key":"10.1016\/j.wneu.2017.07.111_bib4","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminoncol.2009.02.002","article-title":"Targeting tumor angiogenesis","volume":"36","author":"Gaur","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.wneu.2017.07.111_bib5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2017.07.111_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11060-011-0610-9","article-title":"The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles","volume":"105","author":"Nonoguchi","year":"2011","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.07.111_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3171\/2014.9.PEDS14198","article-title":"Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain","volume":"15","author":"Dashti","year":"2015","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.wneu.2017.07.111_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/2152-7806.167084","article-title":"Study of factors determining caregiver burden among primary caregivers of patients with intracranial tumors","volume":"6","author":"Dhandapani","year":"2015","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.wneu.2017.07.111_bib9","first-page":"e311","article-title":"Endonasal endoscopic transsphenoidal resection of tuberculum sella meningioma with anterior cerebral artery encasement","volume":"7","author":"Dhandapani","year":"2015","journal-title":"Cureus"},{"key":"10.1016\/j.wneu.2017.07.111_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.wneu.2016.08.088","article-title":"Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery","volume":"96","author":"Dhandapani","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.111_bib11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4103\/0028-3886.193829","article-title":"Visual outcome in 2000 eyes following microscopic transsphenoidal surgery for pituitary adenomas: protracted blindness should not be a deterrent","volume":"64","author":"Dutta","year":"2016","journal-title":"Neurol India"},{"key":"10.1016\/j.wneu.2017.07.111_bib12","first-page":"418","article-title":"Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas","volume":"126","author":"Dhandapani","year":"2017","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.111_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000411642","article-title":"The risk of cerebral radionecrosis in relation to dose, time and fractionation. A follow-up study","volume":"29","author":"Marks","year":"1985","journal-title":"Prog Exp Tumor Res"},{"key":"10.1016\/j.wneu.2017.07.111_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.wneu.2017.07.111_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-011-0346-8","article-title":"Anti-VEGF therapy in pituitary carcinoma","volume":"15","author":"Ortiz","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2017.07.111_bib16","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/cncr.11295","article-title":"Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma","volume":"97","author":"Cheung","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2017.07.111_bib17","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1200\/JCO.2008.19.1866","article-title":"Bevacizumab reverses cerebral radiation necrosis","volume":"26","author":"Wong","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2017.07.111_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00066-009-2019-3","article-title":"Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve","volume":"186","author":"Mizumoto","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.wneu.2017.07.111_bib19","unstructured":"Korbonits M, Dutta P, Reddy KS, Bhansali A, Gupta P, Rai A, et\u00a0al. Exome sequencing reveals double hit by AIP gene mutation and copy loss of chromosome 11 but negative X-LAG in a pituitary adenoma of a 4 year old child with gigantism treated with multimodal therapy. Abstract presented at: Endocrine Society's 98th Annual Meeting and Expo. April 1-4, 2016; Boston, MA."},{"key":"10.1016\/j.wneu.2017.07.111_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00066-010-2184-4","article-title":"Bevacizumab as a treatment option for radiation-induced cerebral necrosis","volume":"187","author":"Matuschek","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.wneu.2017.07.111_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jocn.2007.09.004","article-title":"Radiation-induced optic neuropathy","volume":"15","author":"Danesh-Meyer","year":"2008","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2017.07.111_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.0004-8461.2003.01237.x","article-title":"Radiation-induced brain disorders in patients with pituitary tumours","volume":"48","author":"Bhansali","year":"2004","journal-title":"Australas Radiol"},{"key":"10.1016\/j.wneu.2017.07.111_bib23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ijrobp.2007.11.045","article-title":"Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin)","volume":"70","author":"Finger","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2017.07.111_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/WNO.0b013e3182607381","article-title":"Novel treatment for radiation optic neuropathy with intravenous bevacizumab","volume":"32","author":"Farooq","year":"2012","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.wneu.2017.07.111_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","volume":"333","author":"Ferrara","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.wneu.2017.07.111_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-009-9801-z","article-title":"Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis","volume":"94","author":"Torcuator","year":"2009","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.07.111_bib27","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-13-1941","article-title":"Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain","volume":"20","author":"Jiang","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2017.07.111_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajo.2006.09.014","article-title":"Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy","volume":"143","author":"Finger","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.wneu.2017.07.111_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(03)02920-2","article-title":"Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats","volume":"981","author":"Jo\u015bko","year":"2003","journal-title":"Brain Res"},{"issue":"Suppl 21","key":"10.1016\/j.wneu.2017.07.111_bib30","doi-asserted-by":"crossref","first-page":"S543","DOI":"10.4103\/2152-7806.168067","article-title":"Serum lipid profile spectrum and delayed cerebral ischemia following subarachnoid hemorrhage: is there a relation?","volume":"6","author":"Dhandapani","year":"2015","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.wneu.2017.07.111_bib31","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdq702","article-title":"Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab","volume":"22","author":"Tebbutt","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2017.07.111_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/WNO.0b013e3181a58fd1","article-title":"Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab","volume":"29","author":"Hosseini","year":"2009","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.wneu.2017.07.111_bib33","first-page":"252","article-title":"Two patients with brain tumors who received bevacizumab and radiotherapy: optic neuropathy and quality-of-life issues","volume":"4","author":"Fu","year":"2013","journal-title":"J\u00a0Adv Pract Oncol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017312111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017312111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:20:22Z","timestamp":1761812422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875017312111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":33,"alternative-id":["S1878875017312111"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.07.111","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bevacizumab for Radiation Induced Optic Neuritis Among Aggressive Residual\/Recurrent Suprasellar Tumors: More Than a Mere Antineoplastic Effect","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.07.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}